{"id":122220,"date":"2024-11-05T05:35:51","date_gmt":"2024-11-04T22:35:51","guid":{"rendered":"https:\/\/hotvideos24.online\/?p=122220"},"modified":"2024-11-05T05:35:51","modified_gmt":"2024-11-04T22:35:51","slug":"viking-therapeutics-stock-falling-amid-results-for-new-glp-1-pill","status":"publish","type":"post","link":"https:\/\/hotvideos24.online\/?p=122220","title":{"rendered":"Viking Therapeutics stock falling amid results for new GLP-1 pill"},"content":{"rendered":"<p> <script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3711241968723425\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-format=\"fluid\"\r\n     data-ad-layout-key=\"-fb+5w+4e-db+86\"\r\n     data-ad-client=\"ca-pub-3711241968723425\"\r\n     data-ad-slot=\"7910942971\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><br \/>\n<\/p>\n<div>\n<p class=\"yf-1pe5jgt\"><!-- HTML_TAG_START -->Viking Therapeutics (<a data-i13n=\"cpos:1;pos:1\" href=\"https:\/\/finance.yahoo.com\/quote\/VKTX\" data-ylk=\"slk:VKTX;cpos:1;pos:1;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">VKTX<\/a>) shares are taking a dive in Monday&#8217;s session despite on rising manufacturing concerns and competition between pharmaceutical rivals in the GLP-1 weight-loss drug space. Viking reported positive results for<a data-i13n=\"cpos:2;pos:1\" href=\"https:\/\/finance.yahoo.com\/video\/viking-therapeutics-roblox-trump-media-152721165.html\" data-ylk=\"slk:its new obesity pill;cpos:2;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;\" class=\"link  yahoo-link\"> its new obesity pill<\/a>, its breakthrough overshadowed not too soon after by other names in the space.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1pe5jgt\"><!-- HTML_TAG_START --><a data-i13n=\"cpos:3;pos:1\" href=\"https:\/\/www.yahoo.com\/author\/julie-hyman\/?.tsrc=fin-srch\" data-ylk=\"slk:Julie Hyman;cpos:3;pos:1;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Julie Hyman<\/a> and <a data-i13n=\"cpos:4;pos:1\" href=\"https:\/\/www.yahoo.com\/author\/josh-lipton\/\" data-ylk=\"slk:Josh Lipton;cpos:4;pos:1;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Josh Lipton<\/a> report on the latest for Viking Therapeutics&#8217; phase 1 trial results and the latest out of the ObesityWeek conference in San Antonio, Texas.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1pe5jgt\"><!-- HTML_TAG_START -->To watch more expert insights and analysis on the latest market action, check out more Market Domination <a data-i13n=\"cpos:5;pos:1\" href=\"https:\/\/finance.yahoo.com\/videos\/series\/market-domination\/\" data-ylk=\"slk:here;cpos:5;pos:1;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">here<\/a>.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1pe5jgt\"><!-- HTML_TAG_START --><em>This post was written by <\/em><a data-i13n=\"cpos:6;pos:1\" href=\"https:\/\/www.yahoo.com\/author\/luke-carberry-mogan\/\" data-ylk=\"slk:Luke Carberry Mogan;cpos:6;pos:1;elm:context_link;itc:0;sec:content-canvas\" class=\"link \"><em>Luke Carberry Mogan<\/em><\/a><em>.<\/em><!-- HTML_TAG_END --><\/p>\n<section class=\"module-related-videos yf-1ya2447\" data-testid=\"module-related-videos\">\n<header class=\"medium tw-mt-8 mb-4 yf-13lpgjv font-condensed\"> <\/header>\n<\/section><\/div>\n<p><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3711241968723425\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-format=\"fluid\"\r\n     data-ad-layout-key=\"-fb+5w+4e-db+86\"\r\n     data-ad-client=\"ca-pub-3711241968723425\"\r\n     data-ad-slot=\"7910942971\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><br \/>\n<br \/><div data-type=\"_mgwidget\" data-widget-id=\"1660802\">\r\n<\/div>\r\n<script>(function(w,q){w[q]=w[q]||[];w[q].push([\"_mgc.load\"])})(window,\"_mgq\");\r\n<\/script>\r\n<br \/>\n<br \/><a href=\"https:\/\/finance.yahoo.com\/video\/viking-therapeutics-stock-falling-amid-210056194.html\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Viking Therapeutics (VKTX) shares are taking a dive in Monday&#8217;s session despite on rising manufacturing concerns and competition between pharmaceutical rivals in the GLP-1 weight-loss drug space. Viking reported positive &hellip; <a href=\"https:\/\/hotvideos24.online\/?p=122220\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-122220","post","type-post","status-publish","format-standard","hentry","category-business","entry"],"_links":{"self":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/posts\/122220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=122220"}],"version-history":[{"count":0,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/posts\/122220\/revisions"}],"wp:attachment":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=122220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=122220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=122220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}